EcoDrugPlus

Bcl-2-Like Protein 1

Ensembl ID : ENSORLG00000024903
Gene Symbol: LOC101165300
3 Cross references
216 Possible Orthologues:

Beta-2 Adrenergic Receptor

Ensembl ID : ENSORLG00000002214
Gene Symbol: LOC101159524
3 Cross references
192 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSORLG00000025617
Gene Symbol: BACE1
4 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSORLG00000012906
Gene Symbol: BDKRB1
4 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSORLG00000028182
Gene Symbol: BDKRB2
4 Cross references
161 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b

Ensembl ID : ENSORLG00000010308
Gene Symbol: LOC101173893
3 Cross references
224 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b

Ensembl ID : ENSORLG00000009983
Gene Symbol: LOC101156228
3 Cross references
193 Possible Orthologues:

Cgmp-Inhibited 3',5'-Cyclic Phosphodiesterase A

Ensembl ID : ENSORLG00000008246
Gene Symbol: LOC101174445
3 Cross references
215 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1c Subunit

Ensembl ID : ENSORLG00000014296
Gene Symbol: CACNA1C
4 Cross references
213 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1d Subunit, A

Ensembl ID : ENSORLG00000002583
Gene Symbol: CACNA1DA
4 Cross references
211 Possible Orthologues:

Calcium Channel, Voltage-Dependent, L Type, Alpha 1s Subunit, B

Ensembl ID : ENSORLG00000007431
Gene Symbol: CACNA1SB
1 Cross references
198 Possible Orthologues:

Calcium Channel, Voltage-Dependent, N Type, Alpha 1b Subunit, A

Ensembl ID : ENSORLG00000017749
Gene Symbol: CACNA1BA
4 Cross references
219 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).